Pill Monitor

Tag: FDA requirements

FDA Bioequivalence Standards for NTI Drugs: Special Requirements Explained

FDA Bioequivalence Standards for NTI Drugs: Special Requirements Explained

Explore the FDA's stricter bioequivalence standards for Narrow Therapeutic Index (NTI) drugs, including the 90-111% rule, quality assay limits, and why these special requirements matter for patient safety.

Bioequivalence Studies: What FDA Requires Manufacturers to Prove for Generic Drugs

Bioequivalence Studies: What FDA Requires Manufacturers to Prove for Generic Drugs

Learn what the FDA requires from manufacturers to prove bioequivalence for generic drugs. This guide explains the 80-125 rule, ANDA submissions, biowaivers, and special criteria for narrow therapeutic index drugs.